2022¦~¥ì©lÅܺطs«a¯f¬rÀË¥X·s»DÀW¶Ç¡A¥þ²yOmicron¬Ì±¡§ó¬O¤£Â_¬y¦æÂX¤j¡A¥xÆW¤J¹ÒÀˬ̤Υ»¦a¨¾¬Ì¤W¡A±Á{Omicron¯f¬r«Iŧ«Ü¤jªºÀ£¤O¡F¤é«e¥»¤g¨¾¬Ì¥Í§Þ¼t®a¡ÐÀu¥§§J¥Í§Þ»P¥x¤jÂå¾Ç°|¦X§@¬ã¨s®×¡A´ú¸ÕÅã¥Ü±M§QUC§Þ³N¹ïÅܺطs«a¯f¬r§í¨î²v°ª¹F100¢H¡A¦³§U¹ï§ÜÅܺطs«a¯f¬r¡C
³sÄò¤»¦~Àò±o°ê®a«~½è¼Ð³¹ªºÀu¥§§J¥Í§Þ¡A¤é«e©e°U¥xÆW¤j¾ÇÂå¾Ç°|°w¹ïÅܺطs«a¯f¬r¡]SARS-CoV-2 Alpha¡^¦X§@¬ã¨s¦AÀò«¤j¬ð¯}¡FÀu¥§§J¥Í§Þªí¥Ü¡A¥»¦¸©e°U¥x¤j¬ã¨s®×¥HÀu¥§§Jªº±M§QUC§Þ³N¹ïÅܺطs«a¯f¬rªº§í¨î²v¶i¦æ¬ã¨s´ú¸Õ¡Aµ²ªGÅã¥Ü§í¨î²v°ª¹F100¢H¡A¤½¥q¹Î¶¤¹ï³oÓµ²ªG·P¨ì¤Q¤À®¶¾Ä¡A¹ïUC§Þ³N¤Îl¥Í°Ó«~ªº§Ü¬Ì¦³®Ä©Ê§ó²K«H¤ß¡C
Àu¥§§J¥Í§Þ¸³¨Æªø°¨·çüQ³Õ¤h«ü¥X¡A¦³·P©óÅܺطs«a¯f¬r¤w¦¨¥þ²y¬Ì±¡¬y¦æªº³Ì¤j«Â¯Ù¡AÁöµM¥Ø«e¼sªxªº¬Ì]¬I¥´¥i´î½w«¯g¡A¦ý§ïµ½¤é±`¥Í¬¡¨¾¬Ì½Ã¥Í²ßºD§ó¬O¨¾¬Ìªº®Ú¥»¡A¦]¦¹Äâ¤â¥xÆW¤j¾ÇÂå¾Ç°|¶i¦æ±M§QUC§Þ³N§í¨îÅܺطs«a¯f¬rªº¬ã¨s¡C
°¨·çüQ³Õ¤h³zÅS¡A±M§QUC§Þ³N´¿¦b°ê»Ú³»¦y´Á¥Z¡m°ê»ÚÀô¹Ò¬ã¨s»P¤½¦@°·±d´Á¥Z¡n¡]IJERPH¡^µoªí±M·~¬ã¨s¤å³¹¡A®Ú¾ÚResearchGateºô¯¸²Îp¤½¥¬¡A¦¹½g¤åÄm³Q¤Þ¥Î¶W¹L15,000¦¸¡AÅã¥Ü¨ü¨ì°ê»Ú¶¡Àô¹Ò»P¤½¦@½Ã¥Í¦w¥þ±M®a¾ÇªÌªº«µøªÖ©w¡C
°¨·çüQ³Õ¤h©IÆ~¡Aªñ¤é¥xÆW¹Ò¥~²¾¤JOmicron®×¨Ò«ùÄò§e²{¤G¦ì¼ÆÀË¥X¡A¥»¤gOmicron¬ð¯}·P¬V®×¨Ò¤]¶}©l¥X²{¡A°ê¤H¦b¿ì¤½«Ç¡B¾Ç®Õ¡BÂåÀø°|©Ò¡B¾÷³õ¡B®ÈÀ]µ¥¤½¦@³õ©Ò©Î©~®a¥Í¬¡¨¾¬Ì¤W¡A¥iɧU¦³¤½ÃÒ³æ¦ìÅçÃÒªº¨¾¬Ì°Ó«~¡A¤É¯Å¹ïÅܺدf¬rªº§Ü¬Ì±þµß¡A°µ¦n¨¾½d±¹¬I¡C
2022¦~·s¬K¡A°¨·çüQ³Õ¤h´Á³\¡AÀu¥§§J¦b¨¾¬Ì§ÜµßÃþ²£«~¶}µo»P³]p¤Wºë¯q¨Dºë¡A¨Ã¶i¤@¨Bµo®i§ó°ª¶¥ªºÂåÀø¥Î«~¶µ»PB to Bªº²£·~Ãì¡A¤£Â_°l¨D§ó°ªºÝ§Þ³N¬ð¯}¡A¦b¤j°·±d²£·~Ãì¸É»ôÃöÁä²£«~Àô¸`¡C¦¹¥~¡A±N¸ó¨¬«á¬Ì±¡®É¥Nªº¥Í¬¡®ø¶O«~¡A¥]§t¶}µo§Üµß§Ü¯f¬r¤§¤é±`¥Î«~¡BÃdª«¨t¦C°Ó«~¥H¤Î¶}µo¨ã³ÆÁ{§É¬ã¨s¤§«O°·¹«~µ¥¡A¦b¤j°·±d²£·~»â°ì¦³§ó°·¥þªº¥¬§½»Pµo®i¡C<ºK¿ý¤u°Ó>